RxDoctor Payments Data

Scott Biggins, MD

Hepatology · Seattle, WANPI 1861443145

Payments from drug & device makers

$59,710in general payments, 2019–2025

Across 13 payments — averaging $4593.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$33K
  • Bausch Health US, LLC$22K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$5K
  • Mirum Pharmaceuticals, Inc.$129
$8,261in research payments, 2019–2025

Across 8 payments — averaging $1032.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bausch Health US, LLC$8K

What the payments were for

  • Speaking & faculty fees$4,83397%
  • Food & beverage$1293%

General payments by program year

19
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few hepatology providers in Washingtonto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$19,080
Medicare patients
61
Services billed
153

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tacrolimus27$4,824
Midodrine Hcl11$238

Paid to pharmacies, not to this prescriber.

Other hepatology in Seattle

Where these figures come from

Is this you, or does something look wrong? →